AI could cut prostate MRI time while keeping accuracy
NCT ID NCT06094322
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tested whether new deep learning (AI) technology can make prostate MRI scans faster while still finding suspicious nodules. Researchers compared standard MRI sequences with faster, AI-enhanced versions in 34 adults referred for prostate MRI. The goal was to see if the quicker scans could match standard ones in detecting potential cancer, which could reduce exam time and improve patient comfort.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Deep learning-enhanced MRI sequences
- What this could lead to
- If successful, this could lead to faster, more comfortable prostate MRI exams without losing diagnostic accuracy.
- What could go wrong
- This is a small, early-stage study with only 34 participants, so results may not apply to all patients. The AI technique may not detect all cancers as reliably as standard scans.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Universitaire d'Amiens
Amiens, Picardie, 80000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?